Secondary objectives were to evaluate the differences in OGFR receptor, cAMP, and PKA expression and to evaluate the difference in expression of MOR and OGFR between tumor and healthy tissues from samples of colorectal cancer stored in the Cancer Genome Atlas (TCGA) and Genotype Tissue Expression Project (GTEx). The gene discussed is OPRM1; the disease is neoplasm.